Effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis: A comparative cross-sectional investigation in Côte d'Ivoire.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2022
Historique:
received: 09 03 2022
accepted: 23 07 2022
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

For lymphatic filariasis (LF) elimination, endemic countries must document the burden of LF morbidity (LFM). Community-based screening (CBS) is used to collect morbidity data, but evidence demonstrating its reliability is limited. Recent pilots of CBS for LFM alongside mass drug administration (MDA) in Côte d'Ivoire suggested low LFM prevalence (2.1-2.2 per 10,000). We estimated LFM prevalence in Bongouanou District, Côte d'Ivoire, using a comparative cross-sectional design. We compared CBS implemented independently of MDA, adapted from existing Ministry of Health protocols, to a population-based prevalence survey led by formally trained nurses. We evaluated the reliability of case identification, coverage, equity, and cost of CBS. CBS identified 87.4 cases of LFM per 10,000; the survey identified 47.5 (39.4-56.3; prevalence ratio [PR] 1.84; 95% CI 1.64-2.07). CBS identified 39.7 cases of suspect lymphoedema per 10,000; the survey confirmed 35.1 (29.2-41.5) filarial lymphoedema cases per 10,000 (PR 1.13 [0.98-1.31]). CBS identified 96.5 scrotal swellings per 10,000; the survey found 91.3 (83.2-99.8; PR 1.06 [0.93-1.21]); including 33.9 (27.7-38.8) filarial hydrocoele per 10,000 (PR of suspect to confirmed hydrocele 2.93 [2.46-3.55]). Positive predictive values for case identification through CBS were 65.0% (55.8-73.5%) for filarial lymphoedema; 93.7% (89.3-96.7%) for scrotal swellings; and 34.0% (27.3-41.2%) for filarial hydrocoele. Households of lower socioeconomic status and certain minority languages were at risk of exclusion. Direct financial costs were $0.17 per individual targeted and $69.62 per case confirmed. Our community-based approach to LFM burden estimation appears scalable and provided reliable prevalence estimates for LFM, scrotal swellings and LF-lymphoedema. The results represent a step-change improvement on CBS integrated with MDA, whilst remaining at programmatically feasible costs. Filarial hydrocoele cases were overestimated, attributable to the use of case definitions suitable for mass-screening by informal staff. Our findings are broadly applicable to countries aiming for LF elimination using CBS. The abstract is available in French in the S1 File.

Identifiants

pubmed: 36962795
doi: 10.1371/journal.pgph.0000760
pii: PGPH-D-22-00390
pmc: PMC10022321
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0000760

Informations de copyright

Copyright: © 2022 Simpson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Trop Med Int Health. 2005 Apr;10(4):312-21
pubmed: 15807794
World Health Organ Tech Rep Ser. 1992;821:1-71
pubmed: 1441569
J Trop Med. 2015;2015:260359
pubmed: 25694785
Am J Trop Med Hyg. 2016 Oct 5;95(4):877-884
pubmed: 27573626
Int J Health Geogr. 2020 Sep 9;19(1):34
pubmed: 32907588
BMJ. 1994 Jul 9;309(6947):102
pubmed: 8038641
Public Health. 2012 Mar;126(3):233-236
pubmed: 22325616
Am J Trop Med Hyg. 1996 Jun;54(6):591-5
pubmed: 8686777
PLoS Negl Trop Dis. 2010 Jun 01;4(6):e708
pubmed: 20532228
Lancet Glob Health. 2020 Sep;8(9):e1186-e1194
pubmed: 32827480
Int J Epidemiol. 2004 Jun;33(3):469-76
pubmed: 15020569
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3319
pubmed: 25412180
Soc Sci Med. 2017 Jun;183:37-47
pubmed: 28458073
Int Q Community Health Educ. 2015;35(4):295-316
pubmed: 26470395
PLoS Negl Trop Dis. 2021 Feb 22;15(2):e0009075
pubmed: 33617551
Lancet. 2010 Jan 16;375(9710):239-47
pubmed: 20109925
Wkly Epidemiol Rec. 2015 Sep 18;90(38):489-504
pubmed: 26387149
Clin Infect Dis. 2017 Mar 15;64(6):728-735
pubmed: 27956460
Trans R Soc Trop Med Hyg. 2014 Dec;108(12):751-8
pubmed: 25282001
PLoS Negl Trop Dis. 2007 Oct 31;1(1):e67
pubmed: 17989784
Parasit Vectors. 2014 Oct 11;7:466
pubmed: 25303991
Trop Biomed. 2012 Mar;29(1):24-38
pubmed: 22543600
Int J Epidemiol. 2016 Apr;45(2):565-75
pubmed: 27097747
BMJ. 2016 Jan 15;352:i189
pubmed: 26773001
BMC Infect Dis. 2015 May 16;15:214
pubmed: 25981497
PLoS Negl Trop Dis. 2021 Mar 18;15(3):e0009285
pubmed: 33735242
Parasitol Today. 2000 Dec;16(12):544-8
pubmed: 11121854
PLoS Negl Trop Dis. 2021 Jul 23;15(7):e0009577
pubmed: 34297724
PLoS Negl Trop Dis. 2017 Oct 18;11(10):e0006023
pubmed: 29045419
PLoS Negl Trop Dis. 2016 Sep 15;10(9):e0004914
pubmed: 27631980

Auteurs

Hope Simpson (H)

Department for Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Centre for Global Health Research, Brighton and Sussex Medical School, Brighton, United Kingdom.

Daniele O Konan (DO)

Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, Abidjan, Côte d'Ivoire.

Kouma Brahima (K)

Ministère de la Sante et de l'Hygiène Publique, Programme national de lutte contre les Maladies Tropicales Négligées à Chimiothérapie Préventive (PNLMTN-CP) en Côte d'Ivoire, Abidjan, Côte d'Ivoire.

Jeanne d'Arc Koffi (JD)

Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, Abidjan, Côte d'Ivoire.

Saidi Kashindi (S)

American Leprosy Missions, Greenville, South Carolina, United States of America.
AIM Initiative, Accra, Ghana.

Melissa Edmiston (M)

American Leprosy Missions, Greenville, South Carolina, United States of America.
AIM Initiative, Accra, Ghana.

Stefanie Weiland (S)

American Leprosy Missions, Greenville, South Carolina, United States of America.
AIM Initiative, Accra, Ghana.

Katherine Halliday (K)

Department for Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Rachel L Pullan (RL)

Department for Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Aboulaye Meite (A)

Ministère de la Sante et de l'Hygiène Publique, Programme national de lutte contre les Maladies Tropicales Négligées à Chimiothérapie Préventive (PNLMTN-CP) en Côte d'Ivoire, Abidjan, Côte d'Ivoire.

Benjamin Guibehi Koudou (BG)

Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, Abidjan, Côte d'Ivoire.

Joseph Timothy (J)

Department for Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Classifications MeSH